(Q48578177)

12 February 2018

title

Reduced cholecystokinin levels in the limbic lobe in schizophrenia. A marker for pathology underlying the defect state? (English)

1 reference

12 February 2018

0 references

1 reference

Ferrier IN

1

1 reference

12 February 2018

Crow TJ

2

1 reference

12 February 2018

Farmery SM

3

1 reference

12 February 2018

Roberts GW

4

1 reference

12 February 2018

Owen F

5

1 reference

12 February 2018

Adrian TE

6

1 reference

12 February 2018

Bloom SR

7

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 January 1985

1 reference

12 February 2018

Annals of the New York Academy of Sciences

published in

1 reference

12 February 2018

volume

448

1 reference

12 February 2018

page(s)

495-506

1 reference

12 February 2018

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Increased dopamine-receptor sensitivity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Molecular pathology of schizophrenia: more than one disease process?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

The disabilities of chronic schizophrenia--their nature and the factors contributing to their development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Cerebral ventricular size and cognitive impairment in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Psychiatric disorder with intracranial tumors of limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Epileptic psychosis--diagnostic comparison with process schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Telemetered EEG-EOG During Psychotic Behaviors of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Lateralized temporal-limbic dysfunction and psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Retention deficits after combined amygdalo-hippocampal and selective hippocampal resections in the monkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Syndrome of Klüver and Bucy; reproduced in man by bilateral removal of the temporal lobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Lateralized neuropsychological dysfunction in affective disorder and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Peptides, the limbic lobe and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Gastrin and cholecystokinin in human cerebrospinal fluid. Immunochemical determination of concentrations and molecular heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

CCK-containing terminals in the hippocampus are derived from intrinsic neurons: an immunohistochemical and radioimmunological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Distribution of neuropeptides in the limbic system of the rat: The hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Cholecystokinin receptors are decreased in basal ganglia and cerebral cortex of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Microtopography of methionine-enkephalin, dopamine and noradrenaline in the ventral mesencephalon of human control and Parkinsonian brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Reduction in cholecystokinin-like immunoreactivity in the basal ganglia in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Neuropeptides in Alzheimer type dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

CCK receptors and human neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Reduced cholecystokinin-like and somatostatin-like immunoreactivity in limbic lobe is associated with negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Diagnostic Criteria for Use in Psychiatric Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

A standardized psychiatric assessment scale for rating chronic psychotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Current problems in the measurement of gastrin release. A reproducible measure of physiological gastrin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Reduced high affinity cholecystokinin binding in hippocampus and frontal cortex of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Distribution of cholecystokinin-like peptides in the human-brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Reduced cholecystokinin immunoreactivity in the cerebrospinal fluid of patients with psychiatric disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Cholecystokinin in hippocampal pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Immunohistochemical localization of cholecystokinin- and gastrin-like peptides in the brain and hypophysis of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29943.X

10.1111/J.1749-6632.1985.TB29943.X

21 January 2018

Identifiers

DOI

1 reference

12 February 2018

1 reference

12 February 2018